Medpace Holdings (MEDP) Earnings Date & Reports

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms... Show more

Industry: #Miscellaneous Commercial Services

Get AI intraday signals

A.I. Advisor

published Earnings

MEDP is expected to report earnings to fall 18.80% to $2.98 per share on July 21

Medpace Holdings MEDP Stock Earnings Reports

Q2'25

Est.

$2.98

Q1'25

Beat

by $0.62

Q4'24

Beat

by $0.73

Q3'24

Beat

by $0.23

Q2'24

Beat

by $0.22

The last earnings report on April 21 showed earnings per share of $3.67, beating the estimate of $3.05. With 81.68K shares outstanding, the current market capitalization sits at 12.43B.

View a ticker or compare two or three

Compare

MEDP